Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingyan Tablets (清咽片) is a traditional Chinese medicine (TCM) product manufactured by Sichuan Defeit Pharmaceutical. It is formulated as an oral tablet primarily indicated for the treatment of throat-related conditions, including acute and chronic pharyngitis, sore throat, and hoarseness. The preparation typically functions according to TCM principles by clearing heat, detoxifying, and soothing the throat. While specific ingredient lists for the Sichuan Defeit version are not explicitly detailed in the provided B2B listing, standard Qingyan Pian formulations often contain botanical extracts such as *Isatidis Radix* (Banlangen), *Scutellariae Radix* (Huangqin), and *Mentholum*. The product is currently approved and marketed in China for respiratory and ENT (ear, nose, and throat) health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingyan Tablets.